Literature DB >> 10918187

Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines.

A deFazio1, Y E Chiew, R L Sini, P W Janes, R L Sutherland.   

Abstract

Members of the c-erbB family have been implicated in poor prognosis in breast cancer. Given the propensity for heterodimerisation within the erbB family, the pattern of co-expression of these receptors is likely to be as functionally important as aberrant expression of any given receptor alone. Therefore, the patterns of expression of the receptors, epidermal growth factor receptor (EGF-R), c-erbB-2, c-erbB-3, c-erbB-4, and one of the erbB ligands, heregulin (HRG), were examined in normal and malignant breast cell lines and compared with expression of oestrogen receptor (ER), a classical indicator of good prognosis. There was an inverse correlation between ER and EGF-R mRNA levels, as previously described, but no correlation between either of these receptors and c-erbB-2. c-erbB-3 expression was positively correlated with ER. In contrast, HRG expression was inversely related to ER. Expression of antisense-ER resulted in increased EGF-R mRNA, demonstrating a functional link between the expression of these 2 genes, however, there was no significant change in c-erbB-2 or c-erbB-3 mRNA, suggesting that ER is not directly involved in control of expression of these genes. A comparison of individual erbB receptors and HRG revealed that the majority of lines expressing increased levels of c-erbB-2 also expressed elevated levels of c-erbB-3 mRNA, and none of the cell lines that expressed both c-erbB-2 and either c-erbB-3 or c-erbB-4 expressed the ligand HRG. In summary, the levels of expression of c-erbB-1, -2, -3, and -4 varied in this series of breast cell lines, and the pattern of expression and the relationship of each growth factor receptor to the expression of ER was quite distinct. The lack of expression of HRG in cell lines that express receptors may be indicative of paracrine interactions between erbB ligands and their cognate receptors and may suggest that the ligand and receptors are expressed in different subtypes of breast epithelial cells from which the cell lines are derived. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918187

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  36 in total

1.  Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers.

Authors:  Lily Yen; Naciba Benlimame; Zeng-Rong Nie; Dingzhang Xiao; Taiqi Wang; Ala-Eddin Al Moustafa; Hiroyasu Esumi; Julie Milanini; Nancy E Hynes; Gilles Pages; Moulay A Alaoui-Jamali
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

Review 2.  Cross-talk and modulation of signaling between somatostatin and growth factor receptors.

Authors:  Ujendra Kumar
Journal:  Endocrine       Date:  2011-08-26       Impact factor: 3.633

3.  Autophagy inhibition synergistically enhances anticancer efficacy of RAMBA, VN/12-1 in SKBR-3 cells, and tumor xenografts.

Authors:  Abhijit M Godbole; Puranik Purushottamachar; Marlena S Martin; Constantine Daskalakis; Vincent C O Njar
Journal:  Mol Cancer Ther       Date:  2012-02-14       Impact factor: 6.261

4.  Selection for EGFR gene amplification in a breast epithelial cell line with basal-like phenotype and hereditary background.

Authors:  Saevar Ingthorsson; Thorhallur Halldorsson; Valgardur Sigurdsson; Agla J R Friðriksdottir; Sigridur K Bodvarsdottir; Margret Steinarsdottir; Oskar Johannsson; Magnus K Magnusson; Helga M Ogmundsdottir; Thorarinn Gudjonsson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-17       Impact factor: 2.416

5.  Down-regulation of HIV-1 infection by inhibition of the MAPK signaling pathway.

Authors:  Jian Gong; Xi-hui Shen; Chao Chen; Hui Qiu; Rong-ge Yang
Journal:  Virol Sin       Date:  2011-04-07       Impact factor: 4.327

6.  ADAM12 induces estrogen-independence in breast cancer cells.

Authors:  Roopali Roy; Marsha A Moses
Journal:  Breast Cancer Res Treat       Date:  2011-03-09       Impact factor: 4.872

7.  Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.

Authors:  Sarah E Pitfield; Ianthe Bryant; Desi J Penington; Gar Park; David J Riese
Journal:  Oncol Res       Date:  2006       Impact factor: 5.574

8.  The epidermal growth factor receptor family in breast cancer.

Authors:  Angelos K Koutras; T R Jeffry Evans
Journal:  Onco Targets Ther       Date:  2008-09-01       Impact factor: 4.147

9.  Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.

Authors:  Hui Lyu; Jingcao Huang; Susan M Edgerton; Ann D Thor; Zhimin He; Bolin Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi.

Authors:  Xinmin Zheng; Ross J Resnick; David Shalloway
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.